Description: Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Home Page: www.baxter.com
BAX Technical Analysis
One Baxter Parkway
Deerfield,
IL
60015
United States
Phone:
224 948 2000
Officers
Name | Title |
---|---|
Mr. Jose E. Almeida | Chairman, Pres & CEO |
Mr. James K. Saccaro | Exec. VP & CFO |
Mr. Giuseppe Accogli | Exec. VP & COO |
Mr. Andrew Frye | Pres of Patient Support Systems, Global Surgical Solutions & Enterprise Connectivity |
Mr. Cristiano Franzi | Sr. VP & Pres for EMEA |
Mr. Brian C. Stevens | Sr. VP, Chief Accounting Officer & Controller |
Mr. Talvis P. Love | Sr. VP & Chief Information Officer |
Ms. Clare Trachtman | VP of Investor Relations |
Mr. David S. Rosenbloom | Sr. VP & Gen. Counsel |
Ms. Stacey Eisen | Sr. VP of Global Communications |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 14.2653 |
---|---|
Trailing PE: | 22.35 |
Price-to-Book MRQ: | 4.7926 |
Price-to-Sales TTM: | 1.736 |
IPO Date: | 1981-10-27 |
Fiscal Year End: | December |
Full Time Employees: | 60000 |